Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Shunyao Guo"'
Autor:
Yufeng Li, Tianyu Mao, Jing Wang, Hongrui Zheng, Ziyi Hu, Pingping Cao, Suisui Yang, Lingyun Zhu, Shunyao Guo, Xinfei Zhao, Yue Tian, Hua Shen, Fan Lin
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is currently the standard first-line therapy for EGFR-mutated advanced non-small cell lung cancer (NSCLC). The life quality and survival of this subgroup of patients were
Externí odkaz:
https://doaj.org/article/dc5da63d0f594a2a92f72e48ff294fc7